CBX5 and breast carcinoma: Notably, querying quantitative proteomics data from tissues (Wang et al, 2019) and breast cancer cell lines (Lawrence et al, 2015) indicate KMT5C levels are at least 2–3 orders of magnitude lower than HP1 proteins.